Effect of omega-3 supplementation on inflammatory parameters in patients on chronic ambulatory peritoneal dialysis
Not Applicable
- Conditions
- End Stage Renal Disease.End Stage Renal Disease
- Registration Number
- IRCT201303052417N11
- Lead Sponsor
- Vice Chancellor for Research, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
inclusion criteria: 1- age more than 18 years old.
2- peritoneal dialysis for 3 months at least.
Exclusion criteria: 1- history of malignancy.
2- steatorhea.
3- thrombocytopenia (platelet less than 100000/mm3).
4- coagulopathy.
5- anticoagulation therapy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum Interlukin-6 level. Timepoint: Begining of the study, after 2 months. Method of measurement: ELISA Kit pg/mL.;Serum CRP level. Timepoint: Begining of the study, after 2 months. Method of measurement: ELISA Kit, mg/L.
- Secondary Outcome Measures
Name Time Method